Package 68788-8741-3

{"route": ["ORAL"], "spl_id": "3c847e6e-2f52-43c6-9ba6-83729cb4662f", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313413"], "spl_set_id": ["f0e4eb26-6733-4df6-bb3c-86bf4d976f42"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68788-8741-1)", "package_ndc": "68788-8741-1", "marketing_start_date": "20240920"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (68788-8741-2)", "package_ndc": "68788-8741-2", "marketing_start_date": "20240920"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-8741-3)", "package_ndc": "68788-8741-3", "marketing_start_date": "20240920"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (68788-8741-6)", "package_ndc": "68788-8741-6", "marketing_start_date": "20240920"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (68788-8741-8)", "package_ndc": "68788-8741-8", "marketing_start_date": "20240920"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (68788-8741-9)", "package_ndc": "68788-8741-9", "marketing_start_date": "20240920"}], "brand_name": "tizanidine", "product_id": "68788-8741_3c847e6e-2f52-43c6-9ba6-83729cb4662f", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "68788-8741", "generic_name": "tizanidine", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA076533", "marketing_category": "ANDA", "marketing_start_date": "20240920", "listing_expiration_date": "20261231"}